Table of Contents

company-logo

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. The company was formerly known as ArTara Therapeutics, Inc. and changed its name to Protara Therapeutics, Inc. in May 2020. Protara Therapeutics, Inc. is headquartered in New York, New York.

Protara Therapeutics Dividend Announcement

• Protara Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Protara Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Protara Therapeutics Dividend History

Protara Therapeutics Dividend Yield

Protara Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Protara Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Protara Therapeutics Financial Ratios

P/E ratio-1.38
PEG ratio0.11
P/B ratio0.71
ROE-55.96%
Payout ratio-0.05%
Current ratio9.85
Quick ratio9.85
Cash Ratio5.99

Protara Therapeutics Dividend FAQ

Does Protara Therapeutics stock pay dividends?
Protara Therapeutics does not currently pay dividends to its shareholders.
Has Protara Therapeutics ever paid a dividend?
No, Protara Therapeutics has no a history of paying dividends to its shareholders. Protara Therapeutics is not known for its dividend payments.
Why doesn't Protara Therapeutics pay dividends?
There are several potential reasons why Protara Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Protara Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Protara Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Protara Therapeutics a dividend aristocrat?
Protara Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Protara Therapeutics a dividend king?
Protara Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Protara Therapeutics a dividend stock?
No, Protara Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Protara Therapeutics stocks?
To buy Protara Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Protara Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.